Amgen Inc is near an agreement to buy Onyx Pharmaceuticals Inc, maker of the cancer drug Kyprolis, for about US$125 a share, people familiar with the matter said.
The US$9.16 billion, all-cash deal may be announced as soon as today, said the sources said. The deal may be valued at as much as US$10.5 billion, due to preferred shares, one source said. The price would be 6.9 percent more than South San Francisco, California-based Onyx’s closing price of US$116.96 on Friday.
Kyprolis was approved last year for some patients with multiple myeloma, and may draw more than US$3 billion in revenue by 2021, according to analysts’ estimates compiled by Bloomberg. The deal would give Amgen a likely boost as Kyprolis sales rise, and bolsters an oncology pipeline that will help expand Thousand Oaks, California-based Amgen’s roster of medicines and increase revenue, the foundation of which are drugs such as Aranesp to combat anemia.
The parties agreed to a lower price after they could not resolve a dispute about Onyx drug data requested by Amgen, said one of the people. Amgen had offered US$130 a share, people said previously.
The price may still change slightly, said one of the people, though it was likely to be close to US$125 per share.
The deal is not finalized and may still fall apart.
Onyx had rejected a US$120-a-share overture from Amgen in June and opened itself up to other bidders. AstraZeneca PLC, Pfizer Inc and Novartis AG had also expressed interest, Bloomberg reported last month.
Onyx also sells Nexavar for liver and kidney cancer in partnership with Germany’s Bayer AG. Onyx generated US$362 million revenue last year, with 80 percent coming from Nexavar and the stomach-cancer treatment Stivarga. The company gets a 20 percent royalty on Stivarga from Bayer, which has said it expects the medicine to be a bestseller.
While Amgen’s original US$120-a-share bid was 37 percent more than Onyx’s 20-day average before it was disclosed, the stock soared past that price after the offer became public, signaling investors expected competing offers.
A deal valuing Onyx at as much as US$10.5 billion would be the third-largest acquisition of a biotechnology company in the past three years, according to data compiled by Bloomberg. Since August 2010, 62 biotechnology deals valued at US$50 million or more were announced, with an average disclosed price of US$1.29 billion and an average premium of 55 percent, the data show.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last